FDA Adverse Event Death Summary report: N

KYPHX INFLATABLE BONE TAMP

MDR report key: 1712819 · Received June 4, 2010

Report

Report Number
2953769-2010-00211
Event Type
Death
Date Received
June 4, 2010
Date of Event
November 16, 2009
Report Date
May 14, 2010
Manufacturer
MEDTRONIC SPINE LLC.
Product Code
HRX
PMA / PMN Number
K981251
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

REPORT SOURCE: ARTICLE TITLED, "TUBERCULOUS SPONDYLITIS AND PARAVERTEBRAL ABSCESS FORMATION AFTER KYPHOPLASTY" BY ROLAND IVO, MD, ROLF SOBOTTKE, MD, HARALD SEIFERT, MD, MONIKA ORTMANN, MD, PEER EYSEL, MD. DEVICE NOT RETURNED, FOLLOWED UP WITH AUTHOR.

Description of Event or Problem · 1

IN AN ARTICLE TITLED "TUBERCULOUS SPONDYLITIS AND PARAVERTEBRAL ABSCESS FORMATION AFTER KYPHOPLASTY", THE FOLLOWING EVENT WAS REPORTED: A PHYSICIAN PERFORMED A BALLOON KYPHOPLASTY PROCEDURE IN LEVEL L1 IN A PATIENT WITH AN UNDIAGNOSED PULMONARY AND POSSIBLE SPINAL TUBERCULOSIS. TWO WEEKS POST PROCEDURE, THE PT PRESENTED WITH FEVER AND GENERAL WEAKNESS. AN MRI SCAN REVEALED L1 SPONDYLITIS AND PARAVERTEBRAL ABSCESS FORMATION PROMPTING INTENSIVE ANTIBIOTIC THERAPY, HOWEVER, WITHOUT ANY IMPROVEMENT. EXTENSIVE REVISION SURGERY WITH LAMINECTOMY, POSTERIOR INSTRUMENTATION AND DISC RESECTION WERE PERFORMED, HOWEVER, THE DISCAL BIOPSY BROUGHT ONLY NONSPECIFIC RESULTS. ONLY A SECOND SURGICAL INTERVENTION WITH CORPORECTOMY WITH SUBSEQUENT HISTOLOGIC EXAMINATION POINTED TO A TUBERCULOUS INFECTION CONFIRMED BY PCR AND CULTURES. DESPITE SPECIFIC ANTITUBERCULOSIS TREATMENT, A PSOAS ABSCESS AND A SUPRAINFECTION WITH A RESISTANT (B) (6) DEVELOPED, LEADING TO SEPSIS WITH MULTIPLE ORGAN FAILURE AND DEATH. NO ADD'L INFO WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 KYPHX INFLATABLE BONE TAMP INFLATABLE BONE TAMP HRX MEDTRONIC SPINE LLC. NA UNK

Patients

Seq Age Sex Outcome Treatment
1 70 YR Life Threatening PRE/POSTOPERATIVE. ANTITUBERCULOTIC TREATMENT:| ISONIAZID| ETHAMBUTOL/ANTIMICOBIAL (LINEZOLID): POSTOPERATIVE| ANTIBIOTIC THERAPY (CIPROFLOXACIN:| PYRAZINAMID,| RIFAMPICIN